Opinion/Ideas: Biotech Buyout Watchlist for 2019


07-Jan-2019 21:58 PM



   The excitement of merger and acquisition is back on for the biotechnology sector.  With two buyouts from the back-to-back week of the 2019 year, one was from last week when Bristol Myers Squibb Co (BMY) acquired Celgene Corporation (CELG) for $74 billion,  then this week Eli Lilly and Co (LLY) acquired Loxo Oncology Inc (LOXO) for $8 billion. In case you missed last year ideas/opinion buyout, (LOXO) was on the list.

This led us to share our opinion/ideas for the 2019 year speculation buyout. This is only to be view as opinion/ideas only, you should do your own due diligence before investing in biotech. Here are the top list on our watchlist for the 2019 year. 

    Furthermore, the biotech clinical data update is big mover like today SAGE Therapeutics Inc (SAGE), and Axsome Therapeutics Inc (AXSM) both are up 42.68% and 161.22%, respectively. For biotech enthusiast that look for biotech clinical data for 1Q 2019, our link is here

For risk mitigation, use our site #BiotechCalculation it has over 80% accuracy predicting clinical data results.

Happy investing.

Disclaimer: I (we) do not hold any positions from stocks mentioned above. This is opinion and ideas only. Not to be used as investment advice. Always do your own due diligence and we are not responsible for any trade losses.

Contact us:

Twitter: @BiotechMoney18



Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.